| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 126 | $152.97 | $19,273.98 | -0.8% | -29.8% | -10.4% | |
| Jan 31, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 1,250 | $152.91 | $191,133.00 | -3.0% | -29.8% | -10.4% | |
| Jan 31, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 1,541 | $152.87 | $235,577.45 | -1.1% | -29.8% | -10.4% | |
| Jan 31, 2025 | Boyer David W.51 | Chief Corp. Affairs Officer | Sale+OE | 1,104 | $152.94 | $168,849.40 | -44.6% | -29.8% | -10.4% | |
| Jan 31, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 1,207 | $152.94 | $184,598.58 | -2.8% | -29.8% | -10.4% | |
| Jan 31, 2025 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 1,283 | $152.87 | $196,135.80 | -3.8% | -29.8% | -10.4% | |
| Jan 31, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 2,707 | $152.92 | $413,966.89 | -0.5% | -29.8% | -10.4% | |
| Jan 27, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 146,105 | $149.46 | $21,836,502.65 | -22.1% | -28.2% | -9.6% | |
| Jan 15, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 65,000 | $141.50 | $9,197,549.84 | -19.4% | -32.5% | -6.5% | |
| Dec 31, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 272 | $138.10 | $37,563.20 | -9.8% | -19.0% | +3.9% |